HOME
ABOUT US
SERVICES
ACCESS
FIND A DOCTOR
NEWS
CLINICAL RESEARCH
CLINICAL TRIAL
CONTACT
More
A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells.
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors.Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors.
Anticancer mechanisms of cannabinoids.
Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells.
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma.
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
Antitumorigenic Effects of Cannabinoids beyond Apoptosis.
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
Cannabidiol as potential anticancer drug.
Cannabidiol (CBD) Priming Enhances Cisplatin Killing Of Cancer Cells.
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival.
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.
Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma.
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.
Cannabinoid-associated cell death mechanisms in tumor models.
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells.
Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Cannabinoid receptors as novel targets for the treatment of melanoma.
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis.
Cannabinoids and Cancer.
Cannabinoids and ceramide: Two lipids acting hand-by-hand.
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Cannabinoids, endocannabinoids, and cancer.
Cannabinoids for Cancer Treatment: Progress and Promise.
Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes.
Cannabinoids: potential antitumoral agents?
Cannabis and Cannabinoids.
Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation.
Cannabis in cancer care.
Cannabidiol inhibits angiogenesis by multiple mechanisms.
Ceramide: A new second messenger of cannabinoid action.
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions.
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells.
Differential role of cannabinoids in the pathogenesis of skin cancer.
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders.
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion.
Endocannabinoids as Guardians of Metastasis.
Endocannabinoids in endocrine and related tumours.
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules.
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa.
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells.
Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma.
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma.
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target.
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism.
Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1.
Inhibition of tumor angiogenesis by cannabinoids.
Integrating cannabis into clinical cancer care.
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.
Involvement of PPARc in the antitumoral action of cannabinoids on hepatocellular carcinoma.
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers.
Medical marijuana for cancer.
​Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells.
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
Potentiation of cannabinoid-induced cytotoxicity in Mantle Cell Lymphoma through modulation of ceramide metabolism.
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid.
Preparation and characterization of Δ 9 -tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
​Proapoptotic effect of endocannabinoids in prostate cancer cells.
Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway*.
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth.
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling*.
The antitumor activity of plant-derived non-psychoactive cannabinoids.
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
The endocannabinoid system and cancer: therapeutic implication.
The endocannabinoid system in cancer.
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas.
The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma.
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.
The use of cannabinoids as anticancer agents.
Towards the use of cannabinoids as antitumour agents.
United States patent application publication for phytocannabinoids in the treatment of cancer.
Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
Action of cannabidiol on the anxiety and other effects produced by Δ-9THC in normal subjects.
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies.
Cannabidiol: An Overview of Some Pharmacological Aspects.
Cannabidiol: Promise and Pitfalls.
​Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Cannabidiol in Humans—The Quest for Therapeutic Targets.
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid.
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent.
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Blood pressure regulation by endocannabinoids and their receptors.Blood pressure regulation by endocannabinoids and their receptors.
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.
Is the cardiovascular system a therapeutic target for cannabidiol?
Oxyradical Stress, Endocannabinoids, and Atherosclerosis.
Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation.
Studies investigating the mechanisms of the cardioprotective effects of cannabidiol.
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
Allosteric modulation of the cannabinoid CB1 receptor.
Cannabinoid CB1 receptor binding and acetylcholinesterase inhibitory activity of Sceletium tortuosum L.
Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis.
Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB1 Receptor Antagonism.
​Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice.
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid.
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers.
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons.
Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation.
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.
​CB2 cannabinoid receptors as an emerging target for demyelinating diseases.
Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor.
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.
Role of CB2 receptors in social and aggressive behavior in male mice.
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
​The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.
Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice.
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
Cannabidiol, a therapeutic potential compound, inhibits the catalytic activity of cytochrome.
Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels.
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana.
Survey Results of Pain Treatments in Adults with Cerebral Palsy.
​Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.
Effects of cannabis on cognitive function in patients with multiple sclerosis.
Keep off the grass? Cannabis, cognition and addiction.
Methods of the Pharmacological Imaging of the Cannabinoid System (PhICS) study.
The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells.
Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor.
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines.
Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent.
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Possible endocannabinoid control of colorectal cancer growth.
The cannabinoid δ9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.
Cannabis Alleviates Symptoms Of Crohn’s Disease.
Cannabis finds its way into treatment of Crohn’s disease.
Cannabis Induces a Clinical Response in Patients With Crohn's Disease.
Treatment of Crohn’s Disease with Cannabis.
